ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amphotericin B Liposome for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-14W17140
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Amphotericin B Liposome for Injection Market Research Report 2024
BUY CHAPTERS

Global Amphotericin B Liposome for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-14W17140
Report
November 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
SPH New Asia Pharmaceuticals
Jemincare

Amphotericin B Liposome for Injection Market

The global Amphotericin B Liposome for Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Amphotericin B Liposome for Injection leading manufacturers including Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc., dominate supply; the top five capture approximately % of global revenue, with Gilead Sciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Amphotericin B Liposome for Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Specification and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Amphotericin B Liposome for Injection Market Report

Report Metric Details
Report Name Amphotericin B Liposome for Injection Market
Segment by Specification
  • 2mg
  • 10mg
  • 50mg
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Amphotericin B Liposome for Injection study scope, segments the market by Specification and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Specification, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Specification, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Specification, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Specification, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Specification, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Amphotericin B Liposome for Injection Market report?

Ans: The main players in the Amphotericin B Liposome for Injection Market are Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare

What are the Application segmentation covered in the Amphotericin B Liposome for Injection Market report?

Ans: The Applications covered in the Amphotericin B Liposome for Injection Market report are Hospital, Clinic, Others

1 Study Coverage
1.1 Introduction to Amphotericin B Liposome for Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Specification
1.2.1 Global Amphotericin B Liposome for Injection Market Size by Specification, 2020 VS 2024 VS 2031
1.2.2 2mg
1.2.3 10mg
1.2.4 50mg
1.3 Market Segmentation by Application
1.3.1 Global Amphotericin B Liposome for Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amphotericin B Liposome for Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Amphotericin B Liposome for Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Amphotericin B Liposome for Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Amphotericin B Liposome for Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Amphotericin B Liposome for Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Amphotericin B Liposome for Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 2mg Market Size by Manufacturers
3.5.2 10mg Market Size by Manufacturers
3.5.3 50mg Market Size by Manufacturers
3.6 Global Amphotericin B Liposome for Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Amphotericin B Liposome for Injection Sales Performance by Specification
4.1.1 Global Historical and Forecasted Sales by Specification (2020-2031)
4.1.2 Global Sales Market Share by Specification (2020-2031)
4.2 Global Amphotericin B Liposome for Injection Revenue Trends by Specification
4.2.1 Global Historical and Forecasted Revenue by Specification (2020-2031)
4.2.2 Global Revenue Market Share by Specification (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Specification (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Amphotericin B Liposome for Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Amphotericin B Liposome for Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Amphotericin B Liposome for Injection Sales and Revenue by Specification (2020-2031)
6.4 North America Amphotericin B Liposome for Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Amphotericin B Liposome for Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Amphotericin B Liposome for Injection Sales and Revenue by Specification (2020-2031)
7.4 Europe Amphotericin B Liposome for Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Amphotericin B Liposome for Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Amphotericin B Liposome for Injection Sales and Revenue by Specification (2020-2031)
8.4 Asia-Pacific Amphotericin B Liposome for Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Amphotericin B Liposome for Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Amphotericin B Liposome for Injection Sales and Revenue by Specification (2020-2031)
9.4 Central and South America Amphotericin B Liposome for Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Amphotericin B Liposome for Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Amphotericin B Liposome for Injection Sales and Revenue by Specification (2020-2031)
10.4 Middle East and Africa Amphotericin B Liposome for Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Amphotericin B Liposome for Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Amphotericin B Liposome for Injection Product Models, Descriptions and Specifications
11.1.4 Gilead Sciences Amphotericin B Liposome for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gilead Sciences Amphotericin B Liposome for Injection Sales by Product in 2024
11.1.6 Gilead Sciences Amphotericin B Liposome for Injection Sales by Application in 2024
11.1.7 Gilead Sciences Amphotericin B Liposome for Injection Sales by Geographic Area in 2024
11.1.8 Gilead Sciences Amphotericin B Liposome for Injection SWOT Analysis
11.1.9 Gilead Sciences Recent Developments
11.2 SPH New Asia Pharmaceuticals
11.2.1 SPH New Asia Pharmaceuticals Corporation Information
11.2.2 SPH New Asia Pharmaceuticals Business Overview
11.2.3 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Models, Descriptions and Specifications
11.2.4 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales by Product in 2024
11.2.6 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales by Application in 2024
11.2.7 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales by Geographic Area in 2024
11.2.8 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection SWOT Analysis
11.2.9 SPH New Asia Pharmaceuticals Recent Developments
11.3 Jemincare
11.3.1 Jemincare Corporation Information
11.3.2 Jemincare Business Overview
11.3.3 Jemincare Amphotericin B Liposome for Injection Product Models, Descriptions and Specifications
11.3.4 Jemincare Amphotericin B Liposome for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Jemincare Amphotericin B Liposome for Injection Sales by Product in 2024
11.3.6 Jemincare Amphotericin B Liposome for Injection Sales by Application in 2024
11.3.7 Jemincare Amphotericin B Liposome for Injection Sales by Geographic Area in 2024
11.3.8 Jemincare Amphotericin B Liposome for Injection SWOT Analysis
11.3.9 Jemincare Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Amphotericin B Liposome for Injection Industry Chain
12.2 Amphotericin B Liposome for Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Amphotericin B Liposome for Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Amphotericin B Liposome for Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Amphotericin B Liposome for Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Amphotericin B Liposome for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Gilead Sciences
SPH New Asia Pharmaceuticals
Jemincare
List of Tables
 Table 1. Global Amphotericin B Liposome for Injection Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Amphotericin B Liposome for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Amphotericin B Liposome for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Amphotericin B Liposome for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Amphotericin B Liposome for Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Amphotericin B Liposome for Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Amphotericin B Liposome for Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Amphotericin B Liposome for Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Amphotericin B Liposome for Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Amphotericin B Liposome for Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Amphotericin B Liposome for Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Amphotericin B Liposome for Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B Liposome for Injection as of 2024)
 Table 16. Global Amphotericin B Liposome for Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Amphotericin B Liposome for Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Amphotericin B Liposome for Injection Manufacturing Base and Headquarters
 Table 19. Global Amphotericin B Liposome for Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Amphotericin B Liposome for Injection Sales by Specification (2020-2025) & (K Units)
 Table 23. Global Amphotericin B Liposome for Injection Sales by Specification (2026-2031) & (K Units)
 Table 24. Global Amphotericin B Liposome for Injection Revenue by Specification (2020-2025) & (US$ Million)
 Table 25. Global Amphotericin B Liposome for Injection Revenue by Specification (2026-2031) & (US$ Million)
 Table 26. Global Amphotericin B Liposome for Injection ASP by Specification (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Amphotericin B Liposome for Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Amphotericin B Liposome for Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Amphotericin B Liposome for Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Amphotericin B Liposome for Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Amphotericin B Liposome for Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Amphotericin B Liposome for Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Amphotericin B Liposome for Injection Growth Accelerators and Market Barriers
 Table 37. North America Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Amphotericin B Liposome for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Amphotericin B Liposome for Injection Growth Accelerators and Market Barriers
 Table 40. Europe Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Amphotericin B Liposome for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Amphotericin B Liposome for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Amphotericin B Liposome for Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Amphotericin B Liposome for Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Amphotericin B Liposome for Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Amphotericin B Liposome for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Gilead Sciences Corporation Information
 Table 51. Gilead Sciences Description and Major Businesses
 Table 52. Gilead Sciences Product Models, Descriptions and Specifications
 Table 53. Gilead Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Gilead Sciences Sales Value Proportion by Product in 2024
 Table 55. Gilead Sciences Sales Value Proportion by Application in 2024
 Table 56. Gilead Sciences Sales Value Proportion by Geographic Area in 2024
 Table 57. Gilead Sciences Amphotericin B Liposome for Injection SWOT Analysis
 Table 58. Gilead Sciences Recent Developments
 Table 59. SPH New Asia Pharmaceuticals Corporation Information
 Table 60. SPH New Asia Pharmaceuticals Description and Major Businesses
 Table 61. SPH New Asia Pharmaceuticals Product Models, Descriptions and Specifications
 Table 62. SPH New Asia Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. SPH New Asia Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 64. SPH New Asia Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 65. SPH New Asia Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 66. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection SWOT Analysis
 Table 67. SPH New Asia Pharmaceuticals Recent Developments
 Table 68. Jemincare Corporation Information
 Table 69. Jemincare Description and Major Businesses
 Table 70. Jemincare Product Models, Descriptions and Specifications
 Table 71. Jemincare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Jemincare Sales Value Proportion by Product in 2024
 Table 73. Jemincare Sales Value Proportion by Application in 2024
 Table 74. Jemincare Sales Value Proportion by Geographic Area in 2024
 Table 75. Jemincare Amphotericin B Liposome for Injection SWOT Analysis
 Table 76. Jemincare Recent Developments
 Table 77. Key Raw Materials Distribution
 Table 78. Raw Materials Key Suppliers
 Table 79. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 80. Milestones in Production Technology Evolution
 Table 81. Distributors List
 Table 82. Market Trends and Market Evolution
 Table 83. Market Drivers and Opportunities
 Table 84. Market Challenges, Risks, and Restraints
 Table 85. Research Programs/Design for This Report
 Table 86. Key Data Information from Secondary Sources
 Table 87. Key Data Information from Primary Sources


List of Figures
 Figure 1. Amphotericin B Liposome for Injection Product Picture
 Figure 2. Global Amphotericin B Liposome for Injection Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 2mg Product Picture
 Figure 4. 10mg Product Picture
 Figure 5. 50mg Product Picture
 Figure 6. Global Amphotericin B Liposome for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Amphotericin B Liposome for Injection Report Years Considered
 Figure 11. Global Amphotericin B Liposome for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Amphotericin B Liposome for Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Amphotericin B Liposome for Injection Revenue Market Share by Region (2020-2031)
 Figure 15. Global Amphotericin B Liposome for Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Amphotericin B Liposome for Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Amphotericin B Liposome for Injection Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Amphotericin B Liposome for Injection Sales Volume Market Share in 2024
 Figure 19. Global Amphotericin B Liposome for Injection Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. 2mg Revenue Market Share by Manufacturer in 2024
 Figure 22. 10mg Revenue Market Share by Manufacturer in 2024
 Figure 23. 50mg Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2020-2031)
 Figure 25. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2020-2031)
 Figure 26. Global Amphotericin B Liposome for Injection Sales Market Share by Application (2020-2031)
 Figure 27. Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2020-2031)
 Figure 28. North America Amphotericin B Liposome for Injection Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Amphotericin B Liposome for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Amphotericin B Liposome for Injection Sales Revenue (US$ Million) in 2024
 Figure 31. North America Amphotericin B Liposome for Injection Sales Volume (K Units) by Specification (2020- 2031)
 Figure 32. North America Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Specification (2020 - 2031)
 Figure 33. North America Amphotericin B Liposome for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Amphotericin B Liposome for Injection Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Amphotericin B Liposome for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Amphotericin B Liposome for Injection Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Amphotericin B Liposome for Injection Sales Volume (K Units) by Specification (2020-2031)
 Figure 42. Europe Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 43. Europe Amphotericin B Liposome for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 46. France Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Amphotericin B Liposome for Injection Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Amphotericin B Liposome for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Amphotericin B Liposome for Injection Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Amphotericin B Liposome for Injection Sales Volume (K Units) by Specification (2020- 2031)
 Figure 54. Asia-Pacific Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Specification (2020- 2031)
 Figure 55. Asia-Pacific Amphotericin B Liposome for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 61. India Amphotericin B Liposome for Injection Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Amphotericin B Liposome for Injection Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Amphotericin B Liposome for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Amphotericin B Liposome for Injection Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Amphotericin B Liposome for Injection Sales Volume (K Units) by Specification (2021-2031)
 Figure 66. Central and South America Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 67. Central and South America Amphotericin B Liposome for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Amphotericin B Liposome for Injection Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Amphotericin B Liposome for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Amphotericin B Liposome for Injection Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Amphotericin B Liposome for Injection Sales Volume (K Units) by Specification (2021-2031)
 Figure 75. South America Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 76. Middle East and Africa Amphotericin B Liposome for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Amphotericin B Liposome for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Amphotericin B Liposome for Injection Revenue (2020-2025) & (US$ Million)
 Figure 82. Amphotericin B Liposome for Injection Industry Chain Mapping
 Figure 83. Regional Amphotericin B Liposome for Injection Manufacturing Base Distribution (%)
 Figure 84. Global Amphotericin B Liposome for Injection Production Market Share by Region (2020-2031)
 Figure 85. Amphotericin B Liposome for Injection Production Process
 Figure 86. Regional Amphotericin B Liposome for Injection Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Amphotericin B for Injection Market Research Report 2024
Liposomal Amphoteracin B Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Market Insights Forecast to 2030
Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
AmBisome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bupivacaine Liposome Injection Market Research Report 2024
Global Microsphere Liposomes Market Research Report 2024
Global Liposome Development Service Market Research Report 2025
Global Amphotericin B Market Research Report 2024
Global Mucormycosis Treatment Drugs Market Research Report 2025
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Injection Market Research Report 2025
Global Irinotecan Hydrochloride Liposome Injection Market Research Report 2025
Global Liposome Drug Delivery Market Insights Forecast to 2030
Liposomal Amikacin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal Doxorubicin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Daunorubicin and Cytarabine Market Research Report 2024
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 Fluocytosine Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Dietary Supplement Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions